Control (editing) of the genome within reach, or already in our hands?
Authors:
Radim Brdička 1; Radoslav Omelka 2
Authors place of work:
GHC Genetics, s. r. o., Praha
1; Katedra botaniky a genetiky, Fakulta prírodných vied, Univerzita Konštantína Filozofa v Nitre, SR
2
Published in the journal:
Čas. Lék. čes. 2018; 157: 79-83
Category:
Review Article
Summary
Although different genome editing tools have been around for decades, the recent emergence of cheap, quick, and accessible CRISPR/Cas9 technology has led to a revolution in this field. The technique has the potential to transform medicine from curative into preventive using a gene therapy. An application of genome editing has proven to be effective for both genetic and non-genetic (e.g. infectious) diseases. However, cancer and rare diseases treatment is at the forefront of interest. Concurrently, the legal and ethical frameworks should be discussed, especially as the technology moves towards a modification of the germ cells or embryos. In addition to a precise molecular genetic diagnosis and choosing the best gene therapy approach for a particular individual, an attention should also be paid to the impacts on the entire human population and the next generations. In this review, we summarize the most important applications of CRISPR/Cas9 technology in the field of medicine. Some interesting results from recent years are presented in the context of used approaches and importance for the future developments in medicine. Finally, ethical and legal conditions in relation to different gene editing applications are discussed.
Keywords:
genome editing, gene drive, gene therapy, CRISPR/Cas9
Zdroje
1. Yin H, Kauffman KJ, Anderson DG. Delivery technologies for genome editing. Nat Rev Drug Discov 2017; 16(6): 387–399
2. Gaudelli NM, Komor AC, Rees HA et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 2017; 551(7681): 464–471.
3. Chen JS, Dagdas YS, Kleinstiver BP et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 2017; 550(7676): 407–410.
4. GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 2017; 550: 204–213.
5. Lee PC, Truong B, Vega-Crespo A et al. Restoring ureagenesis in hepatocytes by CRISPR/Cas9-mediated genomic addition to arginase-deficient induced pluripotent stem cells. Mol Ther Nucleic Acids 2016; 5(11): e394.
6. Hirsch T, Rothoeft T, Teig N et al. Generation of the entire human epidermis using transgenic stem cells Nature 2017; 551: 327–332.
7. Locke T. Embryo gene editing gets the go-ahead in UK. Medscape 2016 Feb 01.
8. Mounts EL. Preimplantation genetic diagnosis in the era of genomic medicine. Medscape 2017 Oct 27.
9. Ault A. NAS panel backs human germline editing, with many caveats. Medscape 2017 Feb 14.
10. Lewis R. Gene editing approach may reduce risks, experts say. Medscape 2017 Aug 04.
11. Bonthron DT, Foulkes WD. Genetics meets pathology – an increasingly important relationship. J Pathol 2017; 241(2): 119–122
12. Cai L, Bai H, Mahairaki V et al. A universal approach to correct various HBB gene mutations in human stem cells for gene therapy of beta-thalassemia and sickle cell disease. Stem Cells Transl Med 2018; 7(1): 87–97.
13. Shin JW, Kim KH, Chao MJ et al. Permanent inactivation of Huntington’s disease mutation by personalized allele-specific CRISPR/Cas9. Hum Mol Genet 2016; 25(20): 4566–4576.
14. Jordan B. [First use of CRISPR for gene therapy]. Med Sci (Paris) 2016; 32(11): 1035–1037.
15. Yin H, Xue W, Chen S et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol 2014; 32(6): 551–553.
16. Nelson CE, Hakim CH, Ousterout DG et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 2016; 351(6271): 403–407.
17. Gao X, Tao Y, Lamas V et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature 2018; 553(7687): 217–221.
18. Bakhshinyan D, Adile AA, Qazi MA et al. Introduction to cancer stem cells: past, present, and future. Methods Mol Biol 2018; 1692: 1–16
19. Yik JJ, Crossley M, Quinlan KGR. Genome editing of erythroid cell culture model systems. Methods Mol Biol 2018; 1698: 245–257.
20. Jaiswal A, Peddinti G, Akimov Y et al. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells. Genome Med 2017; 9(1): 51.
21. Romanel A, Garritano S, Stringa B et al. Inherited determinants of early recurrent somatic mutations in prostate cancer. Nat Commun 2017; 8(1): 48.
22. Hu X, Sood AK, Dang CV, Zhang L. The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 2018; 48: 8–15.
23. Shi L, Meng T, Zhao Z. CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes. Gene 2017; 636: 36–41.
24. Guichard SM. CRISPR-Cas9 for drug discovery in oncology. Annu Rep Med Chem 2017; 50: 61–85.
25. Soppe JA, Lebbink RJ. Antiviral goes viral: harnessing CRISPR/Cas9 to combat viruses in humans. Trends Microbiol 2017; 25: 833–850.
26. Dampier W, Sullivan NT, Chung CH et al. Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants. Sci Rep 2017; 7(1): 14413.
27. Wong WF, Santiago M. Microbial approaches for targeting antibiotic-resistant bacteria. Microb Biotechnol 2017; 10: 1047–1053.
28. Kimura M. Evolutionary rate at the molecular level. Nature 1968; 217(5129): 624–626.
29. Hammond A, Galizi R, Kyrou K et al. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol 2016; 34: 78–83.
30. Champer J, Reeves R, Oh SY et al. Novel CRISPR/Cas9 gene drive constructs reveal insights into mechanisms of resistance allele formation and drive efficiency in genetically diverse populations. PLoS Genet 2017; 13(7): e1006796.
31. World Anti-Doping Agency. What is prohibited. WADA, 2017. Dostupné na: www.wada-ama.org/en/prohibited-list/prohibited-at-all-times/gene-doping
32. Petr J. Jsme připravení na „krisprovou“ revoluci? Vesmír 2015; 94(7): 394–395.
33. Chien WW. A CRISPR way to restore hearing. N Engl J Med 2018; 378(13): 1255–1256.
34. Al‑Chalabi A, Brown RH. Finding a treatment for ALS – will gene editing cut it? N Engl J Med 2018; 378(15): 1454–1456.
35. Jasanoff S, Hurlbut JB. A global observatory for gene editing. Nature 2018; 555(7697): 435–437.
36. Burall S. Don’t wait for an outcry about gene editing. Nature 2018; 555(7697): 438–439.
Štítky
Addictology Allergology and clinical immunology Anaesthesiology, Resuscitation and Inten Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric dermatology & STDs Paediatric gastroenterology Paediatric gynaecology Paediatric surgery Paediatric cardiology Paediatric nephrology Paediatric neurology Paediatric clinical oncology Paediatric ENT Paediatric pneumology Paediatric psychiatry Paediatric radiology Paediatric rheumatology Paediatric urologist Diabetology Endocrinology Pharmacy Clinical pharmacology Physiotherapist, university degree Gastroenterology and hepatology Medical genetics Geriatrics Gynaecology and obstetrics Haematology Hygiene and epidemiology Hyperbaric medicine Vascular surgery Chest surgery Plastic surgery Surgery Medical virology Intensive Care Medicine Cardiac surgery Cardiology Clinical speech therapy Clinical microbiology Nephrology Neonatology Neurosurgery Neurology Nuclear medicine Nutritive therapist Obesitology Ophthalmology Clinical oncology Orthodontics Orthopaedics ENT (Otorhinolaryngology) Anatomical pathology Paediatrics Pneumology and ftiseology Burns medicine Medical assessment General practitioner for children and adolescents Orthopaedic prosthetics Clinical psychology Radiodiagnostics Radiotherapy Rehabilitation Reproduction medicine Rheumatology Nurse Sexuology Forensic medical examiner Dental medicine Sports medicine Toxicology Traumatology Trauma surgery Urology Laboratory Home nurse Phoniatrics Pain management Health Care Dental Hygienist Medical studentČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Non-opioid analgesics
- Pathophysiology of pain and its clinical application
- Opioids and new trends in pain therapy
- Back pain treatment